 |
Lisa Licitra (MD), Associate Professor at Milan University, is responsible of Medical Oncology 3, Head and Neck Cancer at Istituto Nazionale dei Tumori, Milan (Italy). From 2018 to 2021 she was Vice President of EORTC (European Organization for Research and Treatment of Cancer) and from 2019 she serves as Scientific Director of the National Center of Oncological Hadrontherapy (CNAO). She is also co-founder and Member of the European Head and Neck Cancer Society, Honorary Member of ESTRO (European Society of Radiation Oncology) and leader of EURACAN (European Network for Rare Adult Solid Cancer). As of August 2024, she has authored 411 scientific articles in peer-reviewed journals. |